PFIZER | UNJHA FORMUL | PFIZER/ UNJHA FORMUL |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 38.7 | 15.5 | 250.1% | View Chart |
P/BV | x | 6.6 | 4.5 | 146.4% | View Chart |
Dividend Yield | % | 0.7 | 0.0 | - |
PFIZER UNJHA FORMUL |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PFIZER Mar-24 |
UNJHA FORMUL Mar-24 |
PFIZER/ UNJHA FORMUL |
5-Yr Chart Click to enlarge
|
||
High | Rs | 4,940 | 25 | 19,863.3% | |
Low | Rs | 3,480 | 11 | 32,985.8% | |
Sales per share (Unadj.) | Rs | 479.4 | 41.3 | 1,161.1% | |
Earnings per share (Unadj.) | Rs | 120.5 | 0.6 | 19,420.2% | |
Cash flow per share (Unadj.) | Rs | 134.1 | 0.8 | 16,737.3% | |
Dividends per share (Unadj.) | Rs | 35.00 | 0 | - | |
Avg Dividend yield | % | 0.8 | 0 | - | |
Book value per share (Unadj.) | Rs | 785.9 | 6.1 | 12,892.3% | |
Shares outstanding (eoy) | m | 45.75 | 4.48 | 1,021.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 8.8 | 0.4 | 2,047.0% | |
Avg P/E ratio | x | 34.9 | 28.5 | 122.4% | |
P/CF ratio (eoy) | x | 31.4 | 22.1 | 142.0% | |
Price / Book Value ratio | x | 5.4 | 2.9 | 184.4% | |
Dividend payout | % | 29.0 | 0 | - | |
Avg Mkt Cap | Rs m | 192,598 | 79 | 242,719.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 3,478 | 6 | 58,949.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 21,932 | 185 | 11,857.5% | |
Other income | Rs m | 1,805 | 0 | 1,504,250.0% | |
Total revenues | Rs m | 23,737 | 185 | 12,825.2% | |
Gross profit | Rs m | 6,433 | 6 | 111,678.8% | |
Depreciation | Rs m | 623 | 1 | 76,888.9% | |
Interest | Rs m | 154 | 1 | 28,574.1% | |
Profit before tax | Rs m | 7,461 | 5 | 165,059.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1,947 | 2 | 111,919.5% | |
Profit after tax | Rs m | 5,513 | 3 | 198,320.1% | |
Gross profit margin | % | 29.3 | 3.1 | 942.3% | |
Effective tax rate | % | 26.1 | 38.5 | 67.8% | |
Net profit margin | % | 25.1 | 1.5 | 1,673.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 27,378 | 38 | 71,820.8% | |
Current liabilities | Rs m | 5,466 | 22 | 24,888.9% | |
Net working cap to sales | % | 99.9 | 8.7 | 1,143.6% | |
Current ratio | x | 5.0 | 1.7 | 288.6% | |
Inventory Days | Days | 115 | 0 | - | |
Debtors Days | Days | 3 | 318 | 1.0% | |
Net fixed assets | Rs m | 14,053 | 11 | 125,359.5% | |
Share capital | Rs m | 458 | 45 | 1,021.0% | |
"Free" reserves | Rs m | 35,498 | -17 | -202,961.1% | |
Net worth | Rs m | 35,955 | 27 | 131,656.5% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 41,748 | 49 | 84,630.9% | |
Interest coverage | x | 49.4 | 9.4 | 526.7% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.5 | 3.7 | 14.0% | |
Return on assets | % | 13.6 | 6.7 | 201.5% | |
Return on equity | % | 15.3 | 10.2 | 150.7% | |
Return on capital | % | 21.2 | 18.5 | 114.3% | |
Exports to sales | % | 3.9 | 0 | - | |
Imports to sales | % | 23.7 | 0 | - | |
Exports (fob) | Rs m | 848 | NA | - | |
Imports (cif) | Rs m | 5,202 | NA | - | |
Fx inflow | Rs m | 848 | 39 | 2,172.2% | |
Fx outflow | Rs m | 5,202 | 0 | - | |
Net fx | Rs m | -4,354 | 39 | -11,159.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,568 | 10 | 25,033.1% | |
From Investments | Rs m | 537 | -1 | -50,186.9% | |
From Financial Activity | Rs m | -2,351 | -1 | 435,444.4% | |
Net Cashflow | Rs m | 754 | 9 | 8,716.8% |
Indian Promoters | % | 0.0 | 36.9 | - | |
Foreign collaborators | % | 63.9 | 0.0 | - | |
Indian inst/Mut Fund | % | 19.6 | 0.0 | - | |
FIIs | % | 3.5 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 36.1 | 63.1 | 57.2% | |
Shareholders | 98,824 | 3,969 | 2,489.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PFIZER With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Pfizer | UNJHA FORMUL | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.81% | 0.99% | 1.23% |
1-Month | -5.07% | -4.98% | -0.24% |
1-Year | 27.47% | 60.31% | 43.62% |
3-Year CAGR | 1.91% | 44.09% | 20.35% |
5-Year CAGR | 5.29% | 28.99% | 26.24% |
* Compound Annual Growth Rate
Here are more details on the Pfizer share price and the UNJHA FORMUL share price.
Moving on to shareholding structures...
The promoters of Pfizer hold a 63.9% stake in the company. In case of UNJHA FORMUL the stake stands at 36.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Pfizer and the shareholding pattern of UNJHA FORMUL.
Finally, a word on dividends...
In the most recent financial year, Pfizer paid a dividend of Rs 35.0 per share. This amounted to a Dividend Payout ratio of 29.0%.
UNJHA FORMUL paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Pfizer, and the dividend history of UNJHA FORMUL.
For a sector overview, read our pharmaceuticals sector report.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.